课题基金 / 基金详情

Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes

Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
2 型糖尿病中核因子红细胞 2 相关因子 2 (NRF2) 和钠-葡萄糖协同转运蛋白 2 (SGLT2) 表达的调节
批准号:
456685
负责人:
Chan John S
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-09-01 至 2022-09-01

项目摘要

项目成果

Chan John S的其他基金

相似基金

相关文献

中文摘要
翻译
糖尿病和高血压是心脏病发展的主要危险因素,包括中风、心脏病发作和肾衰竭。通过胰岛素和葡萄糖转运体钠-葡萄糖抑制剂将血糖维持在正常水平
英文摘要
Diabetes and high blood pressure are major risk factors in the development of heart disease, including stroke, heart attacks and kidney failure. Keeping blood sugar at normal levels with insulin and inhibitors of a glucose transporter called sodium-glucos
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in the Progression of Diabetic Nephropathy: Friend or foe?
Reactive Oxygen Species, Bcl-2-Modifying Factor and Tubular Atrophy in Diabetic Kidneys
海外基金